Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Albert J Ribickas"'
Autor:
Hany Elmariah, Jongphil Kim, Kayla M. Reid, Christopher Cubitt, Andrew Kuykendall, Jeffrey E. Lancet, Rami S. Komrokji, David A. Sallman, Onyee Chan, Kendra Sweet, Albert J Ribickas, Rawan Faramand, Asmita Mishra, Farhad Khimani, Lia Perez, Debra Kessler, Stephanie Dormesy, Joseph Pidala, Claudio Anasetti, Ephraim J. Fuchs, Michael D. Jain, Frederick L. Locke, Marco L. Davila, Nelli Bejanyan, Amy E. DeZern
Publikováno v:
Blood. 140:886-888
Autor:
Hien D. Liu, Julio C. Chavez, Albert J. Ribickas, Claudio Anasetti, Michael D. Jain, Farhad Khimani, Taiga Nishihori, Marco L. Davila, Christina A Bachmeier, Renee Smilee, Frederick L. Locke, Aleksandr Lazaryan, Bijal D. Shah, Ariel Perez Perez
Publikováno v:
Blood. 136:4-5
Introduction: Leukapheresis and adequate cell collection of patient derived T cells is critical in the successful manufacturing of chimeric antigen receptor T cell (CAR-T) therapy. There are limited published data on parameters that might affect qual
Publikováno v:
Cytotherapy. 12(3)
Multiple cell-therapy products require density separation as a part of manufacturing. The traditional method for Ficoll separation, layering cell suspensions over Ficoll in tubes, followed by centrifugation and collection of cells from the interface,
Autor:
Renee Smiley, Janelle Perkins, William J. Janssen, Albert J. Ribickas, Ryan R. Brinkman, Maura Gasparetto, Clay Smith, Shang-Jung Jessica Lee
Acute graft-versus-host disease (GVHD) is diagnosed by clinical and histologic criteria that are often nonspecific and typically apparent only after the disease is well established. Because GvHD is mediated by donor T cells and other immune effector
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a018778dfd0a8d4982fa42d1d5af9a3
https://europepmc.org/articles/PMC2000975/
https://europepmc.org/articles/PMC2000975/
Publikováno v:
Cytotherapy. 16:S49